Chronic cutaneous bacterial hypersensitivity dermopathy: a second case and six year evaluation of the first case.
A case we described and reported 6 years ago as chronic cutaneous granulomatous dermopathy was believed due to bacterial hypersensitivity. We now report a second case with similar features of chronic recurrent indolent inflammatory skin lesions, nondiagnostic skin biopsies, and failure to respond to antibiotics. In the absence of another diagnosis and because of the remarkably similar appearance to the first case, we initiated a therapeutic trial with corticosteroids, which induced a remission. The initial case has now been observed for 6 years, and the patient remains in remission on 5 mg of prednisone on alternate days. The second case was considered consistent with bacterial allergy because of IgG and IgE antibodies against common cutaneous bacteria. As there were no granulomas in the current patient's skin lesions, a new designation, chronic cutaneous bacterial hypersensitivity, has been assigned. The differential diagnosis and criteria for this clinical entity are discussed. Either a remission from prednisone or control with low-dose prednisone may be achieved in this dermopathy, which is both disfiguring and frightening to patients.
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60601.
J A
JA
Bernstein
K G
KG
McGrath
R
R
Patterson
D000328:Adult; D002908:Chronic Disease; D003877:Dermatitis, Contact / Q000175:diagnosis / Q000276:immunology / Q000382:microbiology*; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012874:Skin Diseases, Infectious / Q000150:complications* / Q000276:immunology; D013207:Staphylococcal Skin Infections / Q000150:complications* / Q000175:diagnosis / Q000276:immunology
D007074:Immunoglobulin G; D007073:Immunoglobulin E